Year None20202019201820172016 March 3, 2020 Medicenna Announces Overnight Marketed Offering of Common Shares Go to February 13, 2020 Medicenna Reports Third Quarter Fiscal 2020 Financial Results Go to January 13, 2020 Medicenna Reports Compelling Results from Recurrent Glioblastoma Trial When Compared to an Eligibility-Matched Control Arm Go to January 8, 2020 Medicenna Receives $1.3 Million Through Early Warrant Exercises Go to Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5
January 13, 2020 Medicenna Reports Compelling Results from Recurrent Glioblastoma Trial When Compared to an Eligibility-Matched Control Arm Go to
